| Trial ID: | L1174 |
| Source ID: | NCT04258423
|
| Associated Drug: |
Tacrolimus
|
| Title: |
Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT04258423/results
|
| Conditions: |
Kidney Failure
|
| Interventions: |
DRUG: Tacrolimus|DRUG: Everolimus
|
| Outcome Measures: |
Primary: Glomerular Filtration Rate in Patients Treated With Tacrolimus, Glomerular Filtration Rate, 36 months post-transplant|Glomerular Filtration Rate in Patients Treated With Everolimus, Glomerular Filtration Rate, 36 months post-transplant|Number of Patients Who Experience Transplant Rejection, Biopsy, 36 months post-transplant |
|
| Sponsor/Collaborators: |
Sponsor: Indiana University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
4
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2019-12-19
|
| Completion Date: |
2020-06-27
|
| Results First Posted: |
2023-05-24
|
| Last Update Posted: |
2023-05-24
|
| Locations: |
Indiana University, Indianapolis, Indiana, 46202, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT04258423
|
